初代細胞の世界市場予測(~2023年):造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉

◆英語タイトル:Primary Cells Market by Type (Human Primary Cells, Animal Primary Cells), Origin (Hematopoietic, Blood, Skin, Gastrointestinal, Hepatocytes, Renal, Skeleton & Muscles), End User (Life Science Research & Research Institutes) - Global Forecast to 2023
◆商品コード:BT6489
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年7月31日
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarketsが発行した当調査レポートでは、初代細胞の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別(ヒト、動物)分析、由来別(造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉)分析、エンドユーザー別(ライフサイエンス研究、研究機関)分析、初代細胞の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing.
The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung, renal, heart, skeletal & muscle, and other primary cells. The liver cells segment is expected to register the highest CAGR during the forecast period due to their increasing demand in toxicological and pharmacological studies.

Based on type, the market is segmented into human and animal primary cells. The human primary cells segment is expected to register the highest CAGR during the forecast period owing to the high adoption of human primary cells in the development of novel cancer therapies. Human primary cells are also extensively used for studying human cancerous cell models, in toxicology studies, and in the cosmetic industry.

On the basis of end user, the market is segmented into life science research companies and research institutes. The life science research companies segment is expected to grow at the highest CAGR during the forecast period. The high growth rate can be attributed to the high adoption of primary cells in cell-based experiments and cancer research in life science research companies as well as the increasing number of R&D facilities globally.

Primary Cells Market

The global primary cells market is dominated by North America, followed by Europe. North America will continue to dominate the global primary cells market during the forecast period, however, Asia is expected to witness the highest CAGR, with the growth in this market centered on China and Japan. Increasing number of players launching new human primary cells for research, expansion of pharmaceutical and biotechnology industries, and increasing prevalence of cancer in the region are the major factors driving the growth of the North American market. However, regulatory concerns regarding primary cell culture contamination will restrain the growth of this market. Some of the major players in the primary cells market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics (US), PromoCell (Germany), ZenBio (US), STEMCELL Technologies (Canada), AllCells (US), American Type Culture Collection (US), and Axol Biosciences (UK). These companies have a broad product portfolio with comprehensive features. Key industry players focus on acquisitions to maintain and enhance their position in the primary cells market.

【レポートの目次】

1 Introduction (Page No. – 12)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 22)

4 Premium Insights (Page No. – 25)
4.1 Primary Cells: Market Overview
4.2 Primary Cells Market Share, By Region & Origin, 2018
4.3 Primary Cells Market, By Type, 2018–2023 (USD Million)
4.4 Geographical Snapshot of the Primary Cells Market

5 Market Overview (Page No. – 28)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Cancer Research
5.2.1.2 Advantages of Primary Human Cells Over Cell Lines
5.2.1.3 Increasing Demand for Monoclonal Antibodies
5.2.1.4 Rapid Growth in the Biotechnology and Biopharmaceutical Industries
5.2.1.5 Partnerships, Collaborations, and Acquisitions Strengthening Market Growth
5.2.1.6 Increasing Pharmaceutical Outsourcing
5.2.2 Restraints
5.2.2.1 Concerns Regarding Primary Cell Culture Contamination
5.2.3 Opportunities
5.2.3.1 Advancing Biomedical Research Using Primary Cells in 3D Culture

6 Primary Cells Market, By Origin (Page No. – 34)
6.1 Introduction
6.2 Hematopoietic Cells
6.3 Skin Cells
6.4 Gastrointestinal Cells
6.5 Liver Cells
6.6 Lung Cells
6.7 Renal Cells
6.8 Heart
6.9 Skeletal and Muscle Cells
6.10 Other Primary Cells

7 Primary Cells Market, By Type (Page No. – 45)
7.1 Introduction
7.2 Human Primary Cells
7.3 Animal Primary Cells

8 Primary Cells Market, By End User (Page No. – 49)
8.1 Introduction
8.2 Life Science Research Companies
8.3 Research Institutes

9 Primary Cells Market, By Region (Page No. – 53)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Italy
9.3.3 Germany
9.3.4 France
9.3.5 RoE
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 Rest of Asia
9.5 Rest of the World

10 Competitive Landscape (Page No. – 88)
10.1 Overview
10.2 Market Share Ranking, 2017
10.3 Top Ranking Companies in the Primary Cells Market
10.4 Competitive Scenario
10.4.1 Product Launches
10.4.2 Expansions
10.4.3 Acquisitions

11 Company Profiles (Page No. – 91)
11.1 Thermo Fisher Scientific
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 Recent Developments
11.1.4 MnM View
11.2 Merck KGaA
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Lonza
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Cell Biologics
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.5 Promocell
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.6 Zenbio
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments
11.7 Stem Cell Technologies
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.8 ALLCells
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.9 American Type Culture Collection (ATCC)
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.10 Axol Biosciences
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments

12 Appendix (Page No. – 108)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (71 Tables)

Table 1 Increasing Funding in National Cancer Institute Research, Us
Table 2 Cancer Research Output and Growth (2010–2014)
Table 3 List of Recent Significant Acquisitions
Table 4 Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 5 Hematopoietic Cells, By Type
Table 6 Cancer Research Output, Growth, and Impact, 2010–2014
Table 7 Primary Hematopoietic Cells Market, By Region, 2016–2023 (USD Million)
Table 8 Primary Skin Cells Market, By Region, 2016–2023 (USD Million)
Table 9 Primary Gastrointestinal Cells Market, By Region, 2016–2023 (USD Million)
Table 10 Primary Liver Cells Market, By Region, 2016–2023 (USD Million)
Table 11 Primary Lung Cells in the Market
Table 12 Primary Lung Cells Market, By Region, 2016–2023 (USD Million)
Table 13 Primary Renal Cells in the Market
Table 14 Primary Renal Cells Market, By Region, 2016–2023 (USD Million)
Table 15 Primary Heart Cells Market, By Region, 2016–2023 (USD Million)
Table 16 Primary Skeletal and Muscle Cells Market, By Region, 2016–2023 (USD Million)
Table 17 Other Primary Cells Market, By Region, 2016–2023 (USD Million)
Table 18 Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 19 Human Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 20 Animal Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 21 Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 22 Primary Cells Market for Life Science Research Companies, By Region, 2016–2023 (USD Million)
Table 23 Primary Cells Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 24 Primary Cells Market, By Region, 2016–2023 (USD Million)
Table 25 North America: Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 26 North America: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 27 North America: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 28 North America: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 29 US: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 30 US: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 31 US: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 32 Canada: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 33 Canada: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 34 Canada: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 35 R&D Expenditure for Science and Technology in Europe, 2005 vs 2015 (USD Million)
Table 36 Europe: Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 37 Europe: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 38 Europe: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 39 Europe: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 40 UK: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 41 UK: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 42 UK: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 43 Italy: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 44 Italy: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 45 Italy: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 46 Germany: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 47 Germany: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 48 Germany: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 49 France: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 50 France: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 51 France: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 52 RoE: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 53 RoE: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 54 RoE: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 55 Growth in the Number of Publications in China and Japan, 2010–2014
Table 56 Asia : Primary Cells Market, By Country, 2016–2023 (USD Million)
Table 57 Asia: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 58 Asia: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 59 Asia: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 60 China: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 61 China: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 62 China: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 63 Japan: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 64 Japan: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 65 Japan: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 66 RoA: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 67 RoA: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 68 RoA: Primary Cells Market, By End User, 2016–2023 (USD Million)
Table 69 RoW: Primary Cells Market, By Origin, 2016–2023 (USD Million)
Table 70 RoW: Primary Cells Market, By Type, 2016–2023 (USD Million)
Table 71 RoW: Primary Cells Market, By End User, 2016–2023 (USD Million)

List of Figures (35 Figures)

Figure 1 Primary Cells Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type and Designation
Figure 4 Primary Cells Market: Bottom-Up Approach
Figure 5 Primary Cells Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Primary Cells Market, By Origin, 2018 vs 2023 (USD Billion)
Figure 8 Primary Cells Market, By Type, 2018 vs 2023 (USD Billion)
Figure 9 Primary Cells Market, By End User, 2018 vs 2023 (USD Billion)
Figure 10 Primary Cell Market, By Region, 2018 vs 2023 (USD Billion)
Figure 11 Increasing Cancer Research is Driving the Growth of the Primary Cells Market
Figure 12 North America is Estimated to Command the Largest Market Share in 2018
Figure 13 Human Primary Cells Segment to Register the Highest CAGR During the Forecast Period
Figure 14 Asia to Register the Highest CAGR During the Forecast Period
Figure 15 Primary Cells Market: Drivers, Restraints, & Opportunities
Figure 16 Liver Cells Segment Witness the Highest Growth During the Forecast Period
Figure 17 Human Primary Cells to Witness the Highest Growth During the Forecast Period
Figure 18 Life Science Research Companies to Witness the Highest Growth in the Primary Cells Market During the Forecast Period
Figure 19 Primary Cells Market: Geographic Analysis
Figure 20 North America: Cancer Incidence & Mortality, 2012–2035
Figure 21 North America: Primary Cells Market Snapshot
Figure 22 US: Cancer Incidence & Mortality, 2012–2035
Figure 23 Canada: Cancer Incidence & Mortality, 2012–2035
Figure 24 Europe: Cancer Incidence & Mortality, 2012–2035
Figure 25 UK: Cancer Incidence & Mortality, 2012–2035
Figure 26 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in the UK (2005–2014)
Figure 27 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in Italy (2005–2014)
Figure 28 Germany: Cancer Incidence & Mortality, 2012–2035
Figure 29 Asia: Cancer Incidence & Mortality, 2012–2035
Figure 30 Asia: Primary Cells Market Snapshot
Figure 31 CAGR of Publications in Cancer Research, Medicine, and All Disciplines in China (2005–2014)
Figure 32 Product Launches & Expansions, the Most Adopted Growth Strategy From 2015 to 2018
Figure 33 Thermo Fisher Scientific: Company Snapshot
Figure 34 Merck KGaA: Company Snapshot
Figure 35 Lonza: Company Snapshot



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[初代細胞の世界市場予測(~2023年):造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆